<乌鸦传媒>Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Time Beta-hydroxybutyrate-based stopping point reduced burden on patients May 08, 2023
<乌鸦传媒>Study: VA Surgeons Who Do Colonoscopies May Need More Training Outdone by gastroenterologists in finding adenomatous polyps May 08, 2023
<乌鸦传媒>Even at Stage IV, Immunotherapy Helps in Pancreatic Cancer Small but clear boost to overall survival May 07, 2023
<乌鸦传媒>Medicaid Expansion Seen Lifting Colon Cancer Screening for Low-Income People But not a cure-all in states boosting eligibility May 06, 2023
<乌鸦传媒>Food 'Swamps' Tied to Elevated Mortality From Obesity-Related Cancers Study suggests diet is not necessarily a modifiable risk factor for all, editorialists say May 05, 2023
<乌鸦传媒>Mysterious White Blood Cell Disorder Not Just 'AIDS Without HIV' Idiopathic CD4 lymphocytopenia not so heterogenous after all May 03, 2023
<乌鸦传媒>Implanted Ultrasound Device Opening Blood-Brain Barrier Promising in Brain Tumors Device allows delivery of more potent chemotherapies to patients with glioblastomas May 03, 2023
<乌鸦传媒>B-Cell Stimulating Factors Tied to Lymphoma in Sjogren's Findings may bolster interest in BTK inhibitors for autoimmune diseases May 02, 2023
<乌鸦传媒>Novel Chemo Delivery System Achieves High Response Rate in Bladder Cancer Complete responses in 73% of patients with BCG-unresponsive non-muscle-invasive disease May 02, 2023
<乌鸦传媒>Upfront Systemic Therapy, Deferred Surgery Pass Muster in Advanced Kidney Cancer Two studies suggest no harm from deferred cytoreduction, potential benefits of immunotherapy May 02, 2023
<乌鸦传媒>Thriving After Cancer Tara Sanft, MD, on how clinicians can support patients through difficult times May 02, 2023 podcast
<乌鸦传媒>'Fantastic,' 'Terrific' Results With Oncolytic Virus Combo for Bladder Cancer Complete response rate of 85% in BCG-unresponsive non-muscle-invasive disease May 01, 2023
<乌鸦传媒>Enzalutamide-ADT Cuts Risk for Disease Spread in Nonmetastatic Prostate Cancer Combo has potential to be new standard of care in patients with high-risk BCR, expert says Apr 30, 2023
<乌鸦传媒>FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset Apr 28, 2023
<乌鸦传媒>Sperm Donor Banned Over Incest Fears; COVID Hampered Teen Sex; Jerry Springer Dies Health news and commentary from around the Web gathered by 乌鸦传媒 staff Apr 28, 2023
<乌鸦传媒>Sodium Thiosulphate Not Much Help for Calciphylaxis in CKD Though used off-label for years, treatment isn't very beneficial Apr 26, 2023
<乌鸦传媒>Blinatumomab Plus Chemo Effective in Aggressive Infant ALL Low incidence of relapse after treatment "remarkable," researchers say Apr 26, 2023
<乌鸦传媒>HIPEC With Mitomycin C Reduces Locoregional Recurrence in High-Risk Colon Cancer No increase in adverse events or toxicity versus surgery alone Apr 26, 2023
<乌鸦传媒>Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Dive News, features, and commentary about cancer-related issues Apr 21, 2023
<乌鸦传媒>Manufacturer's Troponin Reference Values Don't Apply to Kids Different thresholds for myocardial injury suggested for pediatric patients Apr 21, 2023
<乌鸦传媒>Awareness of HPV's Link to Cancer Lags as Cases Continue to Increase Clear decline for cervical cancer, awareness of other cancers remains stagnant Apr 21, 2023
<乌鸦传媒>Antibody-Drug Conjugate Gets FDA Thumbs Up for Untreated DLBCL Adding polatuzumab vedotin to a modified version of R-CHOP significantly improved PFS Apr 20, 2023
<乌鸦传媒>Genomics Add Insight Into Worse Colorectal Cancer Outcomes in Black Patients Fewer actionable mutations, less likely to meet genomic criteria for immunotherapy Apr 19, 2023
<乌鸦传媒>CAR T-Cell Therapy Shows Promise in Advanced Kidney Cancer ORR of 30% in patients with CD70-positive disease using off-the-shelf, allogeneic product Apr 19, 2023
<乌鸦传媒>Many With Cancer Predisposition Diseases Unaware of Genetic Status Moreover, a significant proportion do not qualify for genetic screening under current guidelines Apr 19, 2023
<乌鸦传媒>Risks Outweigh Benefits for BSO at Benign Hysterectomy in Younger Women It's less clear-cut for postmenopausal women, study authors say Apr 18, 2023
<乌鸦传媒>Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer All but one patient had a PSA decline after a fractionated dose of 225Ac-J591 Apr 18, 2023
<乌鸦传媒>Novel Antibody Induces Durable Responses in Heavily Pretreated Myeloma Overall response rate of 90% in patients who received highest doses of REGN5459 Apr 18, 2023
<乌鸦传媒>Novel Bispecific Antibody Active in Recurrent/Metastatic Head and Neck Cancer Responses in 37% of patients previously treated with anti-PD-1/L1 agents, platinum chemotherapy Apr 18, 2023
<乌鸦传媒>Responses to PD-1 Blockade Approach 90% in Rare Melanoma "One of the highest tumor response rates we've seen in any cancer," study discussant says Apr 17, 2023
<乌鸦传媒>Including Anti-PD-1 in First-Line Ups Survival in Biliary Tract Cancer Another option for difficult-to-treat disease Apr 17, 2023
<乌鸦传媒>'Potential' New Option for Operable NSCLC Adding perioperative durvalumab to neoadjuvant chemo improved pCR rates, event-free survival Apr 17, 2023
<乌鸦传媒>Adjuvant Combo May Change Practice in High-Risk Liver Cancer Atezolizumab-bevacizumab reduced the risk of recurrence by about 30% Apr 17, 2023
<乌鸦传媒>Personalized Cancer Vaccine Boosts Recurrence-Free Survival in Melanoma Clinical implications apply to virtually all solid tumors and possibly hematologic malignancies Apr 17, 2023
<乌鸦传媒>Taxane, Anthracycline Combo Most Effective in Reducing Breast Cancer Recurrence Chemotherapy regimens with higher cumulative dose provide greatest benefit Apr 14, 2023
<乌鸦传媒>Oral Drug Improves Sunlight Tolerance in Genetic Photosensitivity Disorders Dersimelagon significantly extended time to sun-related prodromal symptoms Apr 12, 2023
<乌鸦传媒>Blood Donor's Sex Makes No Difference for Survival Only difference seen was higher incidence of MRSA infection in recipients of female donor blood Apr 12, 2023
<乌鸦传媒>Older Men Still Overscreened for Prostate Cancer, Survey Says PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it Apr 11, 2023
<乌鸦传媒>SYK Inhibitor Promising in Early Trial of Primary ITP Sovleplenib demonstrated "consistent response" as second-line treatment Apr 11, 2023
<乌鸦传媒>Local Anesthesia Before Breast Cancer Surgery Improves OS in Randomized Trial Intervention is inexpensive, easy to implement, researchers say Apr 07, 2023
